Question:
Which of the following genes responsible for graft rejection in humans?
Which of the following genes responsible for graft rejection in humans?
Updated On: Jul 20, 2024
- Highly polymorphic HLA genes
- APP genes
- hMSH2 gene
- FMR1 gene
Hide Solution
Verified By Collegedunia
The Correct Option is A
Solution and Explanation
The correct option is (A): Highly polymorphic HLA genes.
Was this answer helpful?
0
0
Top Questions on Biogenetic pathways
- The below structure represent the drug:
- GPAT - 2024
- Pharmacognosy
- Biogenetic pathways
- The below structure represent the drug:
- GPAT - 2024
- Pharmacognosy
- Biogenetic pathways
- Which one of the following is an autosomal dominant syndrome in its inheritance?
- GPAT - 2023
- Pharmacognosy
- Biogenetic pathways
- Arrange the following intermediates in the synthesis of isoprenoids in the right sequence
A. Squalence
B. Farnesyl PP
C. Geranyl PP
D. Acetyl CoA
E. Mevalonate
Choose the correct answer from the options given below:- GPAT - 2023
- Pharmacognosy
- Biogenetic pathways
- Which one is not the characteristics of the Hexose Monophosphate Pathway?
- GPAT - 2023
- Pharmacognosy
- Biogenetic pathways
View More Questions
Questions Asked in GPAT exam
- Glycogenic amino acids enter TCA cycle except:
- GPAT - 2025
- Biochemistry
- How much volume of Raw spirit can an excise officer withdraw as sample?
- GPAT - 2025
- Indian Pharmaceutical Industry- An Overview
- Match the following:
(P) Schedule H
(Q) Schedule G
(R) Schedule P
(S) Schedule F2
Descriptions:
(I) Life period of drugs
(II) Drugs used under RMP
(III) List of Prescription Drugs
(IV) Standards for surgical dressing- GPAT - 2025
- Drug therapy
- Minimum manufacturing space for 'Habb-Unani medicine' as per Schedule of D and C Act?
- GPAT - 2025
- Pharma Techniques
- If the label or the container bears the name of an individual or company purporting to be the manufacturer of the drug, which individual or company is fictitious or does not exist, it is:
- GPAT - 2025
- Drug therapy
View More Questions